We hypothesize that the ERK1/2-mediated inflammatory response and vasoconstrictor receptor upregulation works in concert[39] to disturb the normal cerebrovascular reactivity and thereby contribute to development of delayed cerebral ischemia[44]. The gene discussed is MAPK3; the disease is brain ischemia.